Protein stability: impact upon protein pharmaceuticals.
Davis
G C
GC
Eli Lilly and Company, Indianapolis, Indiana.
D004355:Drug Stability; D011994:Recombinant Proteins / Q000737:chemistry* / Q000627:therapeutic use
D011994:Recombinant Proteins